Human Organic Cation Transporter 1 Protein Levels of Granulocytes Can Optimize Imatinib Therapy in Patients with Chronic Myeloid Leukemia | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Human Organic Cation Transporter 1 Protein Levels of Granulocytes Can Optimize Imatinib Therapy in Patients with Chronic Myeloid Leukemia

Acta Haematol (2015) 133 (2): 199–204.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH

Jaurès B. Mettral
Nicolas Faller
Sandra Cruchon
Loïc Sottas
Thierry Buclin
Laurent Schild
Eva Choong
Aimable Nahimana
Laurent A. Decosterd

Drug Metabolism Letters (2020) 13 (2): 102.

Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients

Siti Maziras Makhtar
Azlan Husin
Abdul Aziz Baba
Ravindran Ankathil

Journal of Genetics (2018) 97 (4): 835.

Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles

Dan Liu
Pengfei Liu
Liye Cao
Quan Zhang
Yaqing Chen

Oncology Letters (2017) 14 (4): 3975.

Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis

Zhi-Ping Jiang
Xie-Lan Zhao
Naoto Takahashi
Sabrina Angelini
Biswajit Dubashi
Li Sun
Ping Xu

Pharmacogenomics (2017) 18 (1): 35.

Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia

Shantashri Vaidya
Kanjaksha Ghosh
Chandrakala Shanmukhaiah
Babu Rao Vundinti

European Journal of Pharmacology (2015) 765: 124.